Veterinary Nebulizer Market

Veterinary Nebulizer Market Analysis

The Veterinary Nebulizer Market size is estimated at USD 287.5 million in 2025, and is expected to reach USD 388.57 million by 2030, at a CAGR of 6.21% during the forecast period (2025-2030).

Veterinary nebulizers are essential devices that convert liquid medications into a fine mist, enabling animals to inhale treatments through a face mask. These devices are widely used to treat respiratory conditions in animals, including kennel cough, asthma, pneumonia, and bronchitis. In recent years, the prevalence of respiratory diseases among pets has been increasing significantly. For instance, in early 2023, Pawprint Oxygen, an oxygen therapy provider for veterinarians, pets, and hospitals, reported a sharp rise in acute respiratory distress syndrome (ARDS) cases in dogs, which raised serious concerns among veterinarians and pet owners. This growing prevalence of respiratory diseases among dogs is directly driving the demand for veterinary nebulizers, thereby contributing to the market's expansion.

Moreover, the growing population of livestock and companion animals further contributes to the market's expansion, as these animals face an increased risk of respiratory disorders. According to the Foreign Agricultural Service (FAS), United States Department of Agriculture (USDA) Official, in 2024 (January-December), China's national cattle herd expanded to 105.09 million head, compared to 102.16 million in 2023. This notable growth in the cattle population emphasizes the increasing need for veterinary healthcare solutions, particularly nebulizers, to effectively address respiratory health challenges.

Furthermore, the companies are launching new veterinary nebulizers, significantly enhancing treatment and diagnostic efficiency. For instance, in April 2023, Duggan Veterinary Supplies unveiled the Flexineb C2 Companion Animal Nebuliser. This machine targets respiratory issues, including feline asthma, upper respiratory infections, and inflammation from conditions like rabbit flu. The nebulizer stands out as a cost-effective, portable, reusable, and easy-to-maintain solution, adept at administering a range of medications to animals. Thus, technological advancements in nebulizers are revolutionizing the treatment of respiratory diseases in animals, signaling growth for the veterinary nebulizer market in the coming years.

In conclusion, the rising prevalence of respiratory diseases and advancements in nebulizer technology are driving the veterinary nebulizer market. This growth is further supported by the increasing livestock and companion animal populations worldwide. However, limited awareness of veterinary respiratory diseases among pet owners and farmers, along with the high cost of advanced nebulizers, is expected to constrain market growth during the forecast period.

Veterinary Nebulizer Market Trends

Companion Animal Type Segment is Expected to Witness Significant Growth Over the Forecast Period

Veterinary nebulizers are pivotal in treating respiratory ailments in pets, notably dogs and cats. By offering a non-invasive method, they ensure medications reach the lungs directly, effectively addressing issues like asthma, bronchitis, and various infections. Modern companion animal nebulizers are compact, portable, and optimized for shorter treatment durations. Further, the market growth is propelled by the surge in pet ownership, the increasing incidence of respiratory disorders, and infectious diseases in animals.

Moreover, the increasing rate of pet ownership globally has significantly driven the growth of the veterinary nebulizer market. In 2023, the "Pets in Australia" survey by Animal Medicines Australia reported that approximately 28.7 million pets reside in 6.9 million Australian households. Pet ownership in the country has risen from 61% to 69% since the pandemic. Similarly, in 2024, the European Pet Food Industry Federation indicated that 166 million households, accounting for 50% of European homes, own one or more of Europe's 352 million pets. This growing pet population has amplified the need for effective respiratory disease treatments in companion animals, thereby boosting the adoption of veterinary nebulizers.

The increasing prevalence of respiratory and infectious diseases in animals is significantly driving the growth of the veterinary nebulizer market. For instance, in July 2024, the Indian Council of Agricultural Research-National Research Centre for Equines, Hisar, along with the National Referral Laboratory for Glanders, confirmed three cases of Glanders disease in horses in Delhi's Azadpur Mandi area. Glanders, a severe respiratory disorder, causes ulceration and nodule formation in the lungs and respiratory tracts of horses, camels, donkeys, and other animals. Similarly, in December 2024, researchers from the University of Pittsburgh identified signs of H5N1 adaptation in domestic cats during a rural outbreak in South Dakota, where several cats exhibited neurological and respiratory symptoms, leading to fatalities. These rising incidences of respiratory and infectious diseases among companion animals are increasing the demand for veterinary nebulizers, as they provide effective treatment for such conditions. Consequently, this growing demand is accelerating the expansion of the veterinary nebulizer market.

In conclusion, driven by the increasing prevalence of respiratory diseases and the rising rate of pet ownership, the companion animal segment is anticipated to experience substantial growth in the coming years.

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

North America is anticipated to drive the veterinary nebulizer market due to several key factors, including the increasing prevalence of livestock and companion animal diseases, advancements in technology, a growing pet population, rising veterinary healthcare spending, and the introduction of new nebulizer products. The incidence of veterinary respiratory diseases in the United States has significantly increased in recent years. The outbreak of a highly contagious canine respiratory illness in November 2023, reported across 14 U.S states, underscores the growing need for effective respiratory treatment solutions. This growing demand is accelerating the adoption of veterinary nebulizers in the region, further bolstering market growth.

Moreover, the increasing poultry production in Canada, along with the higher concentration of birds in confined spaces, is driving a notable rise in respiratory diseases. This increase in confinement leads to ammonia buildup due to poor ventilation, which leads to respiratory tract damage in the birds. For instance, as per Statistics Canada, the total poultry production and disposition in Canada increased to USD 4,548.42 million in 2023 from USD 4,222.14 million in 2022. This surge in poultry production and disposition increases the chances of respiratory disorders in the poultry, further driving the demand for veterinary nebulizers in the region.

Additionally, pet ownership in North America, particularly in the United States, has increased significantly over the years, further boosting veterinary healthcare spending. According to the YouGov United States Dog Owners Report 2023, the percentage of American dog owners grew steadily from 49% in 2021 to 52% in 2022 and reached 56% in 2023. Additionally, according to Statistics Canada, household pet (cats and dogs) ownership in Canada increased to 12.22 million in 2024 from 11.95 million in 2022. This growing trend in pet ownership has directly contributed to higher expenditures on veterinary healthcare products, thereby driving the demand for nebulizers used in treating animal disorders.

Therefore, owing to the factors mentioned above, including rising respiratory diseases and increasing pet ownership, the growth of the studied market is projected to grow in the North American region.

Veterinary Nebulizer Industry Overview

The veterinary nebulizers market is semi-consolidated in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market share and are well known, including COMPASS HEALTH BRANDS, Duggan Veterinary Supplies Ltd., Nureca Ltd, PARI GmbH, Narang Medical Ltd., Trudell Medical International, Contec Medical Systems Co.,Ltd, Albert Kerbl GmbH, and Witvet Scientific INC., among others.

Veterinary Nebulizer Market Leaders

Veterinary Nebulizer Market News

• March 2025: Researchers showcased the effective application of epinephrine nebulization in post-anesthetic care for a dog suffering from brachycephalic obstructive airway syndrome. The nebulized epinephrine alleviated airway obstruction and diminished the necessity for reintubation by inducing vasoconstriction in the airway mucosal vessels.
• May 2023: PARI officially announced the acquisition of Nortev, a player in the animal nebulization sector. This acquisition represents a critical step in implementing PARI's newly outlined growth and diversification strategy. The move enhances PARI's market position and broadens its presence within the veterinary nebulization market.